Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Sources of Information and Beliefs About the Health Effects of Marijuana.

Ishida JH, Zhang AJ, Steigerwald S, Cohen BE, Vali M, Keyhani S.

J Gen Intern Med. 2020 Jan;35(1):153-159. doi: 10.1007/s11606-019-05335-6. Epub 2019 Oct 21.

PMID:
31637640
2.

Substitution of marijuana for opioids in a national survey of US adults.

Ishida JH, Wong PO, Cohen BE, Vali M, Steigerwald S, Keyhani S.

PLoS One. 2019 Oct 4;14(10):e0222577. doi: 10.1371/journal.pone.0222577. eCollection 2019.

3.

Muscle Relaxant Use Among Hemodialysis Patients: Prevalence, Clinical Indications, and Adverse Outcomes.

Mina D, Johansen KL, McCulloch CE, Steinman MA, Grimes BA, Ishida JH.

Am J Kidney Dis. 2019 Apr;73(4):525-532. doi: 10.1053/j.ajkd.2018.11.008. Epub 2019 Jan 11.

PMID:
30639233
4.

Psychoactive Medications and Adverse Outcomes among Older Adults Receiving Hemodialysis.

Ishida JH, McCulloch CE, Steinman MA, Grimes BA, Johansen KL.

J Am Geriatr Soc. 2019 Mar;67(3):449-454. doi: 10.1111/jgs.15740. Epub 2019 Jan 10.

PMID:
30629740
5.

Perceptions of the Comparative Safety of Different Forms of Marijuana Use Among the Adult US Population.

Yoo SR, Dollinger C, Vali M, Steigerwald S, Cohen BE, Ishida JH, Keyhani S.

J Gen Intern Med. 2019 Apr;34(4):504-506. doi: 10.1007/s11606-018-4741-y. No abstract available.

PMID:
30535750
6.

Authors' Reply.

Ishida JH, McCulloch CE, Steinman MA, Grimes BA, Johansen KL.

J Am Soc Nephrol. 2018 Nov;29(11):2771-2772. doi: 10.1681/ASN.2018080811. Epub 2018 Sep 21. No abstract available.

7.

Smoking, Vaping, and Use of Edibles and Other Forms of Marijuana Among U.S. Adults.

Steigerwald S, Wong PO, Cohen BE, Ishida JH, Vali M, Madden E, Keyhani S.

Ann Intern Med. 2018 Dec 18;169(12):890-892. doi: 10.7326/M18-1681. Epub 2018 Aug 28. No abstract available.

8.

Gabapentin and Pregabalin Use and Association with Adverse Outcomes among Hemodialysis Patients.

Ishida JH, McCulloch CE, Steinman MA, Grimes BA, Johansen KL.

J Am Soc Nephrol. 2018 Jul;29(7):1970-1978. doi: 10.1681/ASN.2018010096. Epub 2018 Jun 5.

9.

Opioid Analgesics and Adverse Outcomes among Hemodialysis Patients.

Ishida JH, McCulloch CE, Steinman MA, Grimes BA, Johansen KL.

Clin J Am Soc Nephrol. 2018 May 7;13(5):746-753. doi: 10.2215/CJN.09910917. Epub 2018 Apr 19.

10.

Associations of lipoproteins with cardiovascular and infection-related outcomes in patients receiving hemodialysis.

Kaysen GA, Grimes B, Dalrymple LS, Chertow GM, Ishida JH, Delgado C, Segal M, Chiang J, Dwyer T, Johansen KL.

J Clin Lipidol. 2018 Mar - Apr;12(2):481-487.e14. doi: 10.1016/j.jacl.2017.12.007. Epub 2017 Dec 27.

11.

Marijuana Use and Estimated Glomerular Filtration Rate in Young Adults.

Ishida JH, Auer R, Vittinghoff E, Pletcher MJ, Reis JP, Sidney S, Johansen KL, Bibbins-Domingo K, Peralta CA, Shlipak MG.

Clin J Am Soc Nephrol. 2017 Oct 6;12(10):1578-1587. doi: 10.2215/CJN.01530217. Epub 2017 Aug 24.

12.

Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of RG7667, a Combination Monoclonal Antibody, for Prevention of Cytomegalovirus Infection in High-Risk Kidney Transplant Recipients.

Ishida JH, Patel A, Mehta AK, Gatault P, McBride JM, Burgess T, Derby MA, Snydman DR, Emu B, Feierbach B, Fouts AE, Maia M, Deng R, Rosenberger CM, Gennaro LA, Striano NS, Liao XC, Tavel JA.

Antimicrob Agents Chemother. 2017 Jan 24;61(2). pii: e01794-16. doi: 10.1128/AAC.01794-16. Print 2017 Feb.

13.

Exclusion of Patients With Kidney Disease From Cardiovascular Trials.

Ishida JH, Johansen KL.

JAMA Intern Med. 2016 Jan;176(1):124-5. doi: 10.1001/jamainternmed.2015.6403. No abstract available.

14.

Receipt of Intravenous Iron and Clinical Outcomes among Hemodialysis Patients Hospitalized for Infection.

Ishida JH, Marafino BJ, McCulloch CE, Dalrymple LS, Dudley RA, Grimes BA, Johansen KL.

Clin J Am Soc Nephrol. 2015 Oct 7;10(10):1799-805. doi: 10.2215/CJN.01090115. Epub 2015 Sep 28.

15.

Phase 1 Randomized, Double-Blind, Placebo-Controlled Study of RG7667, an Anticytomegalovirus Combination Monoclonal Antibody Therapy, in Healthy Adults.

Ishida JH, Burgess T, Derby MA, Brown PA, Maia M, Deng R, Emu B, Feierbach B, Fouts AE, Liao XC, Tavel JA.

Antimicrob Agents Chemother. 2015 Aug;59(8):4919-29. doi: 10.1128/AAC.00523-15. Epub 2015 Jun 8.

16.

Comparison of hospitalization rates among for-profit and nonprofit dialysis facilities.

Dalrymple LS, Johansen KL, Romano PS, Chertow GM, Mu Y, Ishida JH, Grimes B, Kaysen GA, Nguyen DV.

Clin J Am Soc Nephrol. 2014 Jan;9(1):73-81. doi: 10.2215/CJN.04200413. Epub 2013 Dec 26.

17.

Iron and infection in hemodialysis patients.

Ishida JH, Johansen KL.

Semin Dial. 2014 Jan-Feb;27(1):26-36. doi: 10.1111/sdi.12168. Epub 2013 Dec 12. Review.

18.

Dialysis facility profit status and compliance with a black box warning.

Ishida JH, McCulloch CE, Dudley RA, Grimes BA, Johansen KL.

JAMA Intern Med. 2013 Jun 24;173(12):1152-3. doi: 10.1001/jamainternmed.2013.979. No abstract available.

19.

Influence of cannabis use on severity of hepatitis C disease.

Ishida JH, Peters MG, Jin C, Louie K, Tan V, Bacchetti P, Terrault NA.

Clin Gastroenterol Hepatol. 2008 Jan;6(1):69-75. doi: 10.1016/j.cgh.2007.10.021.

Supplemental Content

Loading ...
Support Center